Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

In a move that could reshape how obesity and metabolic disease are treated nationwide, federal health officials unveiled a ...

The price of weight-loss drugs like Wegovy put them out of reach for most people with obesity, but new arrivals and expiring ...

On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...

The weight-loss drug boom is creating a whirlwind of uncertainty for the fitness industry around a very basic question: Will GLP-1 users work out more or less? Why it matters: About 1 in 8 U.S. adults ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Notable: Seattle is up to 54% to earn the No. 1 seed after beating the Panthers on Sunday, according to The Athletic's playoff predictor. If they beat the Niners on Saturday night, they'll win the No.